GT Biopharma, Inc. Stock Analysis & AI Score
GT Biopharma, Inc. (GTBP) has an ST Score of 28.2 (C-), driven by its Growth (B+) and held back by its Profitability (F). Analysts rate it Buy.
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
GT Biopharma, Inc. (GTBP) has an ST Score of 28.2 (C-), driven by its Growth (B+) and held back by its Profitability (F). Analysts rate it Buy.
- Strongest
- GrowthB+
- Weakest
- ProfitabilityF
All factor grades
- GrowthB+
- Financial StrengthC
- ValuationD+
- MomentumD+
- ProfitabilityF
- Piotroski1/9
Contact
GTBP stock: frequently asked questions
What is GTBP's ST Score?
GT Biopharma, Inc. (GTBP) has an ST Score of 28.2 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is GTBP a buy, hold, or sell?
Analysts rate GTBP a Buy. Our ST Score grades it C- (28.2/100). The ST Score is a data-driven signal, not a recommendation.
What are GTBP's factor grades?
Valuation D+, Profitability F, Financial Strength C, Momentum D+, Growth B+.
What is GTBP's valuation grade?
GT Biopharma, Inc. (GTBP) earns a valuation grade of D+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is GTBP's growth grade?
GT Biopharma, Inc. (GTBP) earns a growth grade of B+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is GTBP's profitability grade?
GT Biopharma, Inc. (GTBP) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is GTBP's financial strength grade?
GT Biopharma, Inc. (GTBP) earns a financial strength grade of C, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is GTBP's Piotroski score?
GT Biopharma, Inc. (GTBP) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.